CannabisLink.ca - Top Stories

Top Stories (2026) - (849 items)

(All links open in new tab)

Apr 24, 2026	BC cannabis retailer opens consumption patio A cannabis store in Kamloops, BC, opened the city’s first outdoor smoking patio on April 20, 2026. Taste Cannabis, which has operated in Kamloops since 2022, has fenced off the age-gated space next to the store, restricting access to patrons 19 and older. Only cannabis is allowed to be consumed in the space. Taste Cannabis’ Operator Cody Savard told Castanet that he was inspired by another cannabis store in BC’s interior that has an outdoor consumption space, Penticton’s Cannabis Cottage, which opened on April 20, 2024, following provincial rule changes earlier that year.
Apr 24, 2026	What Happens When Cannabis Magazines are Too Scandalous for Dispensaries? Fat Nugs Magazine’s Kids and Cannabis issue tackled a tough but necessary conversation. A partner dispensary refused to carry it. What does that say about the industry’s willingness to advance the cannabis conversation?
Apr 24, 2026	Canadian Cannabis Sales Continued to Advance in February Statistics Canada released February retail sales for the country, with cannabis sales decreasing from the January levels, down 7.9% to C$440.5 million from the prior month. The sequential decrease was up 2.0% on a per-day basis more due to the fewer days than in the prior month. January, originally reported at C$466.1 million, was revised higher to C$478.2 million. The sales in February were up 7.9% from a year ago, down from the level last month at 9.4% and in May at 8.3% and 7.5% in June but better than the prior lowest annual growth rate since legalization commenced of -0.9% in September 2024 due to the BC strike. In 2024, total sales increased 4.5% to C$5.39 billion, and they were up 4.1% in 2025 to C$5.62 billion. So far in 2026, sales are up 8.6%.
Apr 24, 2026	What to Know About Trump’s Reclassification of Medical Marijuana On April 23, acting U.S. attorney general Todd Blanche signed an order changing the federal classification of medical marijuana. The move, which came at the behest of President Donald Trump and will make the substance a Schedule 3 drug, will bring enormous tax benefits to medical marijuana producers in the 40 states where medical use is legal and may speed research into its effects, experts say. But it does not legalize marijuana at the federal level, nor does it change the status of marijuana grown for recreational use. Here’s what you need to know.
Apr 24, 2026	Reclassifying marijuana as a less dangerous drug might only be the first step for Trump U.S. President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry: It gives dispensaries a big tax break, eases some barriers to researching cannabis and could even allow the export of marijuana to other countries. But that might only be Trump’s first step. A new administrative hearing slated for the end of June could result in the reclassification of marijuana more broadly, granting tax and other benefits to state-licensed recreational markets, too.
Apr 23, 2026	Trump’s Rescheduling Move Could Change the Cannabis Industry Overnight The scheduling reclassification does not legalize cannabis use under federal law, but it will impact the 40 states that have approved medical cannabis programs. The directive for rescheduling also provides a tax incentive to state-licensed medical cannabis operators. Medical cannabis is defined by a drug product made from the Cannabis plant or derivatives that can legally be marketed under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Apr 23, 2026	Department of Justice officially reschedules marijuana: What truckers need to know Moving marijuana onto the Schedule III controlled substance list might in future make medically-prescribed cannabis a possibility in some form or fashion for CDL drivers. Yet given the lack of an absolutely effective way to test for impairment beyond cannabis-problematic urine tests, it's likely a very long time coming.
Apr 23, 2026	Trump’s Rescheduling Move Could Change the Cannabis Industry Overnight Acting U.S. Attorney General (AG) Todd Blanche signed an order Thursday to reclassify state-licensed medical cannabis as a less dangerous substance. The order shifts the designation of licensed medical cannabis from Schedule I –the most restrictive category of drug classification for substances that have no medical value and potential for abuse including heroin– to the less restrictive Schedule III for substances, or chemicals, defined as drugs with a moderate-to-low potential for physical and psychological dependence alongside Tylenol with Codeine, ketamine, anabolic steroids, and testosterone.
Apr 23, 2026	Cannabis Use Associated With Lower Likelihood of Metabolic Disorders, Including Hypertension, Type 2 Diabetes, and Obesity Hangzhou, China: Those with a history of cannabis use possess a lower risk of suffering from metabolic disorders – including hypertension, type 2 diabetes, and obesity, according to data published in the journal Nutrition, Metabolism & Cardiovascular Diseases. Chinese researchers assessed the relationship between cannabis use and metabolic syndromes in a nationally representative sample of 91,000 adults.
Apr 23, 2026	Trump Pushes Congress To Keep Full-Spectrum CBD Legal While Restricting Hemp Products That Pose ‘Health Risks’ President Donald Trump is urging congressional lawmakers to take action to amend a law that threatens to federally recriminalize hemp-derived full-spectrum CBD products in November.
Apr 23, 2026	Cannabis Stocks Lose Buzz Despite This Landmark Decision Cannabis stocks rose Thursday after the Trump administration, in a landmark decision, reclassified marijuana as a less-dangerous drug. But early stock gains faded. Marijuana now goes from being classified among the most dangerous drugs to Schedule III, a federal designation for drugs with a moderate to low potential for dependence and abuse.
Apr 23, 2026	Market Outlook: U.S. cannabis reclassification drives stock surge Marijuana stocks surged after the U.S. Department of Justice reclassified cannabis to a lower-risk category, easing restrictions in a major policy shift.
Apr 23, 2026	Trump administration eases rules on some marijuana categories. Here's what to know The Trump administration is easing rules on medical marijuana, moving it out of the restrictive Schedule I and into Schedule III — a category shared by drugs such as Tylenol with codeine and anabolic steroids.
Apr 23, 2026	Marijuana Reclassification Explained: What the Trump Administration’s Schedule 3 Move Actually Means On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law. If you’re trying to understand what that actually means — for dispensaries, patients, cannabis businesses and federal policy — this is the explainer.
Apr 22, 2026	‘We’re not going anywhere’: Victoria Cannabis Buyers Club raided Tuesday A day after the annual 4/20 day, the Victoria Police Department raided the Victoria Cannabis Buyers Club, a longstanding unlicensed cannabis club in Victoria. The dispensary is known for selling products with a high level of THC to mostly low-income people with chronic illnesses. “People’s lives are at stake here, we’re not going to give up because of a raid or two or four,” said Ted Smith, founder of VCBC, reiterating, “People’s lives are at stake, I don’t think the provincial government understands that.”
Apr 22, 2026	Canada’s cannabis export dominance remains despite global price compression, rising standards The global medical cannabis market is growing quickly but inconsistently, with tightening regulatory environments and a competitive supply chain where margins are universally compressing, according to the newest market report from the Global Cannabis Exchange.
Apr 22, 2026	US set to move to reclassify marijuana as early as Wednesday, Axios reports WASHINGTON, April 22 (Reuters) - The United States administration is expected to move to ?reclassify marijuana as soon as Wednesday, Axios reported, ?citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher. The decision to reclassify marijuana would represent one of the ?most significant federal changes to marijuana policy in ?decades, removing barriers to researching the drug's potential ?use cases.
Apr 22, 2026	Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics. It comes just days after one of the country’s largest and most widely respected polling companies, YouGov, published the results of a representative survey examining the British public’s attitudes towards cannabis.
Apr 22, 2026	Six Out Of Ten Americans Support Legalizing Marijuana, New Poll Shows Americans broadly favor legalizing marijuana for recreational or medical purposes, with support across party lines, according to a new poll. The YouGov survey from published on Monday found that 59 percent of U.S. adults want to legalize cannabis—including 75 percent of Democrats, 50 percent of Republicans and 54 percent of independents.
Apr 22, 2026	Rosin, Raids and Risk: Spain’s New Cannabis Frontier On a cold night in late January 2025, a home lab in Espinardo (Murcia) ended in tragedy. Two young men were killed when a butane-based cannabis extraction attempt went catastrophically wrong. As the local press later reported, the pair had been attempting to produce highly concentrated hash oil — BHO, short for butane hash oil — by blasting cannabis with flammable gas. The blast leveled the walls, igniting a deadly fire.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43